Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SPARK BIOMEDICAL INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-07-14 to 2025-11-02
Current total value of award: $1149775.19
Description: MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR ARMY STTR PHASE II PROPOSAL NO. A2-9471 TITLED DEVELOPMENT AND TESTING OF A MILITARY-GRADE WEARABLE TRANSCUTANEOUS AURICULAR NEUROSTIMULATION DEVICE TO RESTORE PERFORMANCE AFTER ACUTE STRESS REACTION.